Healthcare MoneyTree™ report: Q4 2017

PwC and CB Insights' Healthcare MoneyTree™ report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.

For full analysis of Q4’17 activity across all sectors, refer to the PwC/CB Insights MoneyTree™ Report.

Healthcare MoneyTree™ report: Q4 2017

Highlights for this quarters' report include, but are not limited to:
  • With twenty mega-rounds in 2017, US Healthcare annual funding reaches $14.4B, with 98 more deals than 2016. 
  • As compared to Q3’17, the amount of dollars raised by the Biotechnology related industries increased 43%, but the Medical Devices & Equipment related industries decreased 38%.
  • Of the seven mega-rounds in Q4’17, four were expansion stage deals, two were late stage deals, while the last deal was with an early stage company.
  • Globally, deals and dollars invested remained constant with $5.6B in 303 deals in Q4’17 and $5.9B in 308 deals Q3’17.


Contact us

Greg Vlahos
Partner, US Pharmaceuticals and Life Sciences , PwC US
Tel: +1 (408) 817 5029

Laura Robinette
US Pharmaceutical and Life Sciences Assurance Leader
Tel: +1 (919) 791 4100

Tim Weld
US Health Services Assurance Leader, PwC US
Tel: +1 (646) 471 2477

Follow us